Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice

Japanese Journal of Pharmacology

Volumn 83, Issue 2, 2000, Pages 113-118

  Mori, Tomohisa ^a   Baba, Jun ^a   Ichimaru, Yasuyuki ^a   Suzuki, Tsutomu ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Methamphetamine; Morphine; Phencyclidine; Rolipram; SKF81297

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CYCLIC AMP; DOPAMINE 2 RECEPTOR; METHAMPHETAMINE; MORPHINE; PHENCYCLIDINE; PHOSPHODIESTERASE IV; ROLIPRAM;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DRUG EFFECT; LOCOMOTION; MOUSE; NONHUMAN;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BENZAZEPINES; DOPAMINE AGENTS; LOCOMOTION; MALE; METHAMPHETAMINE; MICE; MORPHINE; PHENCYCLIDINE; PHOSPHODIESTERASE INHIBITORS; ROLIPRAM;

EID: 0033936795     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.83.113     Document Type: Article

References (35)

1. Koob GF and Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 242, 715-723 (1988)
2. 2A receptors. Eur J Pharmacol 280, R9-R11 (1995)
3. Nestler EJ, Berhow MT and Brodkin ES: Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol Psychiatry 1, 190-199 (1996)
4. Gleason SD and Shannon HE: Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology (Berl) 129, 79-84 (1997)
5. Di Chiara G and Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85, 5274-5278 (1988)
6. Spanagel R, Herz A and Shippenberg TS: The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study. J Neurochem 55, 1734-1740 (1990)
7. Sibley DR and Monsma FJ Jr: Molecular biology of dopamine receptors. Trends Pharmacol Sci 13, 61-69 (1992)
8. 1 receptor agonists in mice and rats: relation between behavioral effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213, 259-267 (1992)
9. 2 dopamine receptors in the modulation of the reinforcing effect of brain stimulation. Behav Neurosci 107, 161-165 (1993)
10. 1- receptor agonist-induced hyperactivity in mice. Jpn J Pharmacol 73, 251-254 (1997)
11. Gorelick DA and Balster RL: Phencyclidine (PCP). In Psychopharmacology, the Fourth Generation of Progress, pp 1767-1776, Edited by Bloom FE and Kupfer DJ, Raven Press, New York (1995)
12. Wachtel H: Characteristic behavioral alternations in rats by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology (Berl) 77, 309-316 (1982)
13. Iyo M, Maeda Y, Inada T, Kitao Y, Sasaki H and Fukui S: The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior. Neuropsychopharmacology 13, 33-39 (1995)
14. Iyo M, Bi Y, Hashimoto K, Inada T and Fukui S: Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram. Eur J Pharmacol 312, 163-170 (1996)
15. Terwilliger RZ, Beither-Johnson D, Sevarino KA, Crain SM and Nestler EJ: A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 548, 100-110 (1991)
16. Miserendino MJD and Nestler EJ: Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res 674, 299-306 (1995)
17. Tolliver BK, Ho LB, Reid MS and Berger SP: Evidence for involvement of ventral tegmental area cyclic AMP system in behavioral sensitization to psychostimulants. J Pharmacol Exp Ther 278, 411-420 (1996)
18. Standifer KM and Pasternak GW: G protein and opioid receptor-mediated signaling. Cell Signal 9, 237-248 (1997)
19. Ito C, Onodera K, Sakurai E, Sato M and Watanabe T: Effects of dopamine antagonists on neuronal histamine release in the striatum of rats subjected to acute and chronic treatment with methamphetamine. J Pharmacol Exp Ther 279, 271-276 (1996)
20. Funada M, Narita M, Suzuki T, Misawa M and Nagase H: Modification of morphine-induced locomotor activity by pertussis toxin: Biochemical and behavioral studies in mice. Brain Res 619, 163-172 (1993)
21. Narita M, Suzuki T, Funada M, Misawa M and Nagase H: Involvement of delta-opioid receptor in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system. Psychopharmacology (Berl) 111, 423-426 (1993)
22. Kevavian JW and Calne DB: Multiple receptors for dopamine. Nature 277, 93-96 (1979)
23. Seeman P: Brain dopamine receptors. Pharmacol Rev 32, 229-313 (1980)
24. Iorio LC, Barnett A, Leiz FH, Houser VP and Korduba CA: SCH23390, a potential benzazepine antipsychotic with unique interaction on dopaminergic systems. J Pharmacol Exp Ther 226, 462-468 (1983)
25. Christensen AV, Arnt J, Hyttel J, Larsen JJ and Svendsen O: Pharmacological effects of a specific dopamine D-1 antagonist SCH23390 in comparison with neuroleptics. Life Sci 34, 1529-1540 (1984)
26. Mailman RB, Schulz DW, Lewis MH, Staples L, Rollema H and Dehaven DL: SCH23390: A selective D-1 dopamine antagonist with potent D-2 behavior actions. Eur J Pharmacol 101, 159-160 (1984)
27. Ujike H, Akiyama K, Hamamura T and Otsuki S: Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 98, 89-92 (1989)
28. Funada M, Suzuki T and Misawa M: Role of mesolimbic dopamine system in morphine dependence. Ann Psychiatry 5, 1-15 (1995)
29. Wise RA: Neurobiology of addiction. Curr Opin Neurobiol 6, 243-251 (1996)
30. Ogren S and Goldstein M: Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11, 167-177 (1994)
31. 2 dopamine receptor antagonists and catecholamine-depleting agents on the locomotor stimulation induced by dizocilpine in mice. Behav Brain Res 70, 112-151 (1995)
32. Steinpreis RE: The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav Brain Res 74, 45-55 (1996)
33. 2 receptor-mediated behavior in rats. Neurosci Lett 76, 335-338 (1987)
34. 2 receptors in reserpinized rats. Neuropharmacology 26, 1489-1497 (1987)
35. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Sazena PR and Humphrey PPA: VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46, 157-203 (1994)